Berlin, Germany
Yolife GmbH, headquartered in Germany and founded in 2017, is at the forefront of the intersection between biotechnology and digital health. The company operates with the compelling mission encapsulated in its slogan, "Live longer in good health." Yolife's app targets the global issue of aging, aiming to add 15 healthy years to 1 billion people by reducing the risk of age-related diseases like cardiovascular diseases, diabetes, cancer, and Alzheimer’s.
Yolife emphasizes lifestyle changes supported by right instructions, superior experience design, and a conducive social environment. Their ambitions align with the rising trend of rejuvenation therapies and anti-aging drug discoveries, highlighting Yolife as a potential gateway to these advances.
With a recent €8.80M angel investment from notable individuals such as Mikko Kodisoja, Leena Niemistö, Timo Soininen, and Markku Kaloniemi, Yolife is poised for growth. They present a unique opportunity for investors to participate in the next evolutionary step in human longevity.
